Home > Insider Trading > Filing (0001144204-10-008501)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1418919	Cpex Pharmaceuticals Inc.	CPEX	Pharmaceutical Preparations (2834)	261172076

Insiders

Cik	Name	Reported Address	Director	Officer	Large Shareholder	Other
1475843	Arcadia Capital Advisors, Llc	175 Great Neck Road Suite 406 Great Neck NY 11021	No	No	Yes	No
1479796	Arcadia Opportunity Master Fund, Ltd	175 Great Neck Road Ste 406 Great Neck NY 11021	No	No	Yes	No
1479797	Md Sass Finstrat Arcadia Capital Holdings, Llc	175 Great Neck Road Ste 406 Great Neck NY 11021	No	No	Yes	No
1480078	S James Frank	666 E Garland Des Plaines IL 60016	No	No	Yes	No
1480082	S Richard Rofe	54 Meadow Woods Road Great Neck NY 11020	No	No	Yes	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock, Par Value $0.01	Disposition	2010-02-11	500	$15.98	209,658	No	4	S	Direct
Common Stock, Par Value $0.01	Disposition	2010-02-11	500	$16.02	209,158	No	4	S	Direct
Common Stock, Par Value $0.01	Disposition	2010-02-11	2,071	$16.19	207,087	No	4	S	Direct
Common Stock, Par Value $0.01	Disposition	2010-02-12	2,820	$16.07	204,267	No	4	S	Direct
Common Stock, Par Value $0.01	Disposition	2010-02-16	50,109	$15.74	154,158	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock, Par Value $0.01	99,367	Indirect	By Arcadia Opportunity Master Fund, Ltd.

Footnotes

These securities are owned solely and directly by Mr. James Frank, who is a member of a "group" with the other Reporting Persons for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended (the "Exchange Act").
These securities are owned solely and directly by Arcadia Opportunity Master Fund, Ltd. (the "Fund"), which is a member of a "group" with Mr. James Frank for purposes of Section 13(d) of the Exchange Act. Arcadia Capital Advisors, LLC, a Delaware limited liability company, is the investment manager ("Investment Manager") of the Fund and has discretionary investment authority over the Fund's assets. The managing member of the Investment Manager is M.D. Sass FinStrat Arcadia Capital Holdings, LLC (the "Managing Member").
Richard Rofe is the managing director and a principal of the Investment Manager and serves as the portfolio manager of the Fund, subject to the oversight of the Managing Member and the Investment Manager. All Reporting Persons (other than the Fund) disclaim beneficial ownership of these securities, except to the extent of their pecuniary interest therein, if any, and this report shall not be deemed an admission that any such Reporting Person is the beneficial owner of the securities for purposes of Section 16 of the Exchange Act or for any other purpose.